typical glp 1 weight loss GLP-1 drugs leave users low on key nutrients, study finds GLP-1 Weight Loss Results Timeline

These results suggest that semaglutide may counteract the pathological remodelling processes that occur in response to pressure overload, thereby potentially slowing the progression of RV dysfunction

Tirzepatide treatment was not associated with excess cardiovascular risk (54, 74)

What Happened

Do GLP-1 receptor agonists increase the risk of breast cancer

The SURPASS trial (NCT04093752) will compare tirzepatide with liraglutide in high-risk patients with T2DM, while the SURMOUNT MMO study (NCT05556512) will evaluate the impact of tirzepatide on morbidity and mortality in patients with obesity

Mather M, Joo Yoo H, Clewett DV, et al